Patents by Inventor Renée DOUVILLE

Renée DOUVILLE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Endogenous retrovirus-k (ERVK) encodes an alternate envelope protein
    Patent number: 12064407
    Abstract: The present disclosure relates to an endogenous Retrovirus K protein (ERVK) with an alternative envelope protein titled CTXLP. Said CTXLP peptide is represented by the sequences set forth in SEQ ID NO: 1. Additionally, antibodies that specifically recognize the epitope(s) set forth in SEQ ID NO:1 are and methods of use thereof and kits comprising the peptide set forth in SEQ ID NO:1 are also included in the present disclosure.
    Type: Grant
    Filed: October 17, 2018
    Date of Patent: August 20, 2024
    Assignee: UNIVERSITY OF WINNIPEG
    Inventors: Renée Douville, Mamneet Gurm
  • ENDOGENOUS RETROVIRUS-K (ERVK) ENCODES AN ALTERNATE ENVELOPE PROTEIN
    Publication number: 20230064896
    Abstract: The present disclosure relates to an endogenous Retrovirus K protein (ERVK) with an alternative envelope protein titled CTXLP. Said CTXLP peptide is represented by the sequences set forth in SEQ ID NO: 1. Additionally, antibodies that specifically recognize the epitope(s) set forth in SEQ ID NO:1 are and methods of use thereof and kits comprising the peptide set forth in SEQ ID NO:1 are also included in the present disclosure.
    Type: Application
    Filed: October 17, 2018
    Publication date: March 2, 2023
    Inventors: Renée DOUVILLE, Mamneet GURM